A randomised trial comparing gemcitabine vs TS-1 in patients with resected pancreatic cancer.
Phase 3
- Conditions
- resected pancreas cancer
- Registration Number
- JPRN-UMIN000009118
- Lead Sponsor
- Dokkyo Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
age allegy Patietns aggremant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method